Risk transfer beyond reinsurance: the added value of CAT bonds

被引:5
|
作者
Goetze, Tobias [1 ]
Guetler, Marc [1 ]
机构
[1] Braunschweig Inst Technol, Dept Finance, Abt Jerusalem Str 7, D-38106 Braunschweig, Germany
关键词
CAT Bond; Reinsurance; Risk management; CORPORATE DEMAND; COUNTERPARTY RISK; CATASTROPHE BONDS; PANEL-DATA; INSURANCE; SECURITIZATION; IMPACT; DETERMINANTS; PERFORMANCE; MANAGEMENT;
D O I
10.1057/s41288-021-00234-6
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
Reinsurance and CAT bonds are two alternative risk management instruments used by insurance companies. Insurers should be indifferent between the two instruments in a perfect capital market. However, the theoretical literature suggests that insured risk characteristics and market imperfections may influence the effectiveness and efficiency of reinsurance relative to CAT bonds. CAT bonds may add value to insurers' risk management strategies and may therefore substitute for reinsurance. Our study is the first to empirically analyse if and under what circumstances CAT bonds can substitute for traditional reinsurance. Our analysis of a comprehensive data set comprising U.S. P&C insurers' financial statements and CAT bond use shows that insurance companies' choice of risk management instruments is not arbitrary. We find that the added value of CAT bonds mainly stems from non-indemnity bonds and reveal that (non-indemnity) CAT bonds are valuable under high reinsurer default risk, low basis risk and in high-risk layers.
引用
收藏
页码:125 / 171
页数:47
相关论文
共 47 条
  • [41] The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis
    Burg, Lara C.
    Verheijen, Shenna
    Bekkers, Ruud L. M.
    IntHout, Joanna
    Holloway, Robert W.
    Taskin, Salih
    Ferguson, Sarah E.
    Xue, Yu
    Ditto, Antonino
    Baiocchi, Glauco
    Papadia, Andrea
    Bogani, Giorgio
    Buda, Alessandro
    Kruitwagen, Roy F. P. M.
    Zusterzeel, Petra L. M.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (05)
  • [42] Evaluation of the Incremental Value of a Coronary Artery Calcium Score Beyond Traditional Cardiovascular Risk Assessment A Systematic Review and Meta-analysis
    Bell, Katy J. L.
    White, Sam
    Hassan, Omar
    Zhu, Lin
    Scott, Anna Mae
    Clark, Justin
    Glasziou, Paul
    JAMA INTERNAL MEDICINE, 2022, 182 (06) : 634 - 642
  • [43] Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results
    Gardin, Claude
    Pautas, Cecile
    Fournier, Elise
    Itzykson, Raphael
    Lemasle, Emilie
    Bourhis, Jean-Henri
    Ades, Lionel
    Marolleau, Jean-Pierre
    Malfuson, Jean-Valere
    Gastaud, Lauris
    Raffoux, Emmanuel
    Lambert, Juliette
    Braun, Thorsten
    Thomas, Xavier
    Chantepie, Sylvain
    Cluzeau, Thomas
    de Botton, Stephane
    Berthon, Celine
    Boissel, Nicolas
    Duployez, Nicolas
    Terre, Christine
    de Latour, Regis Peffault
    Michallet, Mauricette
    Celli-Lebras, Karine
    Preudhomme, Claude
    Dombret, Herve
    BLOOD ADVANCES, 2020, 4 (09) : 1942 - 1949
  • [44] Does connected vehicle information reduce beyond-visual-range crash risk in foggy freeway conditions? A study based on extreme value theory
    Ren, Wenhao
    Zhao, Xiaohua
    Yao, Ying
    Chen, Chen
    Fu, Qiang
    Zhang, Yaowen
    ACCIDENT ANALYSIS AND PREVENTION, 2025, 217
  • [45] Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy
    van Ginkel, Noor
    van Gennep, Erik J.
    Oosterbaan, Liselot
    Greidanus, Joyce
    Boellaard, Thierry N.
    Wondergem, Maurits
    Vis, Andre N.
    de Reijke, Theo M.
    van Rhijn, Bas W. G.
    Mertens, Laura S.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (03) : 342 - 348
  • [46] The added value of cardiac index and pulse pressure variation monitoring to mean arterial pressure-guided volume therapy in moderate-risk abdominal surgery (COGUIDE): a pragmatic multicentre randomised controlled trial
    Stens, J.
    Hering, J. -P.
    van der Hoeven, C. W. P.
    Boom, A.
    Traast, H. S.
    Garmers, L. E.
    Loer, S. A.
    Boer, C.
    ANAESTHESIA, 2017, 72 (09) : 1078 - 1087
  • [47] Risk-adjustment models for heart failure patients' 30-day mortality and readmission rates: the incremental value of clinical data abstracted from medical charts beyond hospital discharge record
    Lenzi, Jacopo
    Avaldi, Vera Maria
    Hernandez-Boussard, Tina
    Descovich, Carlo
    Castaldini, Ilaria
    Urbinati, Stefano
    Di Pasquale, Giuseppe
    Rucci, Paola
    Fantini, Maria Pia
    BMC HEALTH SERVICES RESEARCH, 2016, 16